Thomas Freeburg
Equibles does not estimate personal net worth.
About Thomas Freeburg
Thomas Freeburg is recorded as CFO at Niki BioSolutions, Inc. (NIKI) since September 1, 2026. Niki BioSolutions, Inc. reported in an 8-K filed October 13, 2026 that Thomas Freeburg was appointed Chief Financial Officer, effective September 1, 2026. Niki BioSolutions, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Niki BioSolutions, Inc. includes Ian Huen (CEO and Chairman), Alidad Mireskandari (COO), Douglas Arner (Board Member) and 3 others.
“On October 9, 2026, the Board of Directors (the “Board”) of Niki BioSolutions, Inc., a Delaware corporation (the “Company”), appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period of two years, commencing as of September 1, 2026, unless terminated sooner by either party.”
Affiliation history
-
Current
2026-09-01–present
Company network
Leadership on record at Niki BioSolutions, Inc.
- Ian Huen CEO, Chairman
- Alidad Mireskandari COO
- Douglas Arner Board Member
- Justin Wu Board Member
- Kira Sheinerman Board Member
- Laura A. Philips Board Member